FDA Breakthrough Device Designation – 2026 FEBRUARY 18
FDA Grants Breakthrough Device Designation to Two NG Biotech Rapid Tests Targeting the World’s Most Dangerous Drug-Resistant Pathogens A designation recognizing innovation against WHO-critical fungal and bacterial threats Santa Maria, CA, USA / Guipry, France, February 18, 2026; In a significant recognition of innovation in the fight against Antimicrobial Resistance (AMR), NG Biotech, in partnership […]
NG BIOTECH AT WHX Labs, DUBAI – 2026 FEBRUARY 10-13
We’re excited to share that NG Biotech will be attending WHX Labs Dubai from February 10 to 13, 2026. We’d be delighted to connect with you during the event. Feel free to stop by our booth S3.B79. Want to meet us there? Schedule a meeting with our team via our → Contact form
NG BIOTECH AT MEDICA, DÜSSELDORF, GERMANY – 2025 NOVEMBER 17-20
We’re pleased to announce that NG Biotech will be attending Medica 2025 from November 17 to 20 as visitors. This will be is a great opportunity to reconnect, share updates on our latest developments, and explore ways to further strengthen our partnership. Want to meet us there? Schedule a meeting with our team via our → Contact form […]
NG BIOTECH AT AAVLD, AURORA, COLORADO – 2025 NOVEMBER 1-2
We’re excited to be attending the AAVLD Annual Meeting (American Association of Veterinary Laboratory Diagnosticians) taking place from November 1st to 2nd in Aurora, Colorado! Come visit us at Booth 329 to discover our latest innovations and solutions for veterinary diagnostics. Let’s connect, share insights, and explore new opportunities to advance animal health together.